News - isavuconazole, Oncology

Filter

Current filters:

isavuconazoleOncology

Popular Filters

Edison analysts' take on Basilea outlook

10-09-2012

The protracted development of antibiotic ceftobiprole has left Swiss biotech firm Basilea Pharmaceutica…

Antibiotics and Infectious diseasesBasilea PharmaceuticaBiotechnologyceftobiproleFinancialisavuconazoleOncologyResearchToctino

Back to top